BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 16, 2024
See today's BioWorld Asia
Home
» Of trispecifics and translational R&D, Sanofi's, Zerhouni urges innovation
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Of trispecifics and translational R&D, Sanofi's, Zerhouni urges innovation
Oct. 11, 2017
By
Shannon Ellis
No Comments
SUZHOU, China – "It is not enough to try to understand the molecular system behind the disease. You have to understand the importance of each partner in that pathway and pick the right pathway."
BioWorld Asia